Genetic variants of the IgA Fc receptor (FcαR, CD89) promoter in chronic hepatitis C patients

Immunogenetics

Volumn 58, Issue 12, 2006, Pages 937-946

  Watanabe, Azuma ^a,b   Shimokawa, Toshibumi ^a   Moriyama, Mitsuhiko ^b   Komine, Fumihiko ^b   Amaki, Shuichi ^b   Arakawa, Yasuyuki ^b   Ra, Chisei ^a  

^a NIHON UNIVERSITY   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronic hepatitis C; Fc receptor; IgA; Promoter; Single nucleotide polymorphism

Indexed keywords

CYTOSINE; FC RECEPTOR; IMMUNOGLOBULIN A; THYMINE;

ADULT; AGED; ARTICLE; CHRONICITY; CONTROLLED STUDY; DISEASE COURSE; DNA SEQUENCE; FEMALE; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; JAPAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HEPATITIS C, CHRONIC; HUMANS; IMMUNOGLOBULIN A; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); RECEPTORS, FC;

HEPATITIS C VIRUS;

EID: 33751216170     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-006-0159-5     Document Type: Article

References (52)

1. Arthur RR, Hassan NF, Abdallah MY, el-Sharkawy MS, Saad MD, Hackbart BG, Imam IZ (1997) Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 91:271-274
2. Bertoletti A, Ferrari C (2003) Kinetics of the immune response during HBV and HCV infection. Hepatology 38:4-13
3. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S (1961) The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 21:43-57
4. Coverdale SA, Samarasinghe DA, Lin R, Kench J, Byth K, Khan MH, Crewe E, Liddle C, George J, Farrell GC (2003) Changes in antipyrine clearance and platelet count, but not conventional liver tests, correlate with fibrotic change in chronic hepatitis C: value for predicting fibrotic progression. Am J Gastroenterol 98:1384-1390
5. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ (1994) Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19:1513-1520
6. Geissmann F, Launay P, Pasquier B, Lepelletier Y, Leborgne M, Lehuen A, Brousse N, Monteiro RC (2001) A subset of human dendritic cells expresses IgA Fc receptor (CD89), which mediates internalization and activation upon cross-linking by IgA complexes. J Immunol 166:346-352
7. Gowans EJ, Jones KL, Bharadwaj M, Jackson DC (2004) Prospects for dendritic cell vaccination in persistent infection with hepatitis C virus. J Clin Virol 30:283-290
8. Grossetete B, Viard JP, Lehuen A, Bach JF, Monteiro RC (1995) Impaired Fcα receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients. AIDS 9:229-234
9. Grossetete B, Launay P, Lehuen A, Jungers P, Bach JF, Monteiro RC (1998) Down-regulation of Fcα receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. Kidney Int 53:1321-1335
10. Guechot J, Poupon RE, Giral P, Balkau B, Giboudeau J, Poupon R (1994) Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 20:388-393
11. Halfon P, Bourliere M, Penaranda G, Deydier R, Renou C, Botta-Fridlund D, Tran A, Portal I, Allemand I, Rosenthal-Allieri A, Ouzan D (2005) Accuracy of hyaluronic acid level for predicting liver fibrosis stages in patients with hepatitis C virus. Comp Hepatol 4:6
12. Heystek HC, Moulon C, Woltman AM, Garonne P, van Kooten C (2002) Human immature dendritic cells efficiently bind and take up secretory IgA without the induction of maturation. J Immunol 168:102-107
13. Hoofnagle JH (2002) Course and outcome of hepatitis C. Hepatology 36:S21-S29
14. Janoff EN, Wahl SM, Thomas K, Smith PD (1995) Modulation of human immunodeficiency virus type 1 infection of human monocytes by IgA. J Infect Dis 172:855-858
15. Kerr MA (1990) The structure and function of human IgA. Biochem J 271:285-296
16. Kozlowski PA, Black KP, Shen L, Jackson S (1995) High prevalence of serum IgA HIV-1 infection-enhancing antibodies in HIV-infected persons. Masking by IgG. J Immunol 154:6163-6173
17. Lamm ME (1997) Interaction of antigens and antibodies at mucosal surfaces. Annu Rev Microbiol 51:311-340
18. Launay P, Grossetete B, Arcos-Fajardo M, Gaudin E, Torres SP, Beaudoin L, Patey-Mariaud de Serre N, Lehuen A, Monteiro RC (2000) Fcα receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-IgA complexes in patients and CD89 transgenic mice. J Exp Med 191:1999-2009
19. Lerat H, Rumin S, Habersetzer F, Berby F, Trabaud MA, Trepo C, Inchauspe G (1998) In vivo tropism of hepatitis C virus genomic sequences in hematopoietic cells: influence of viral load, viral genotype, and cell phenotype. Blood 91:3841-3849
20. Maliszewski CR, March CJ, Schoenborn MA, Gimpel S, Shen L (1990) Expression cloning of a human Fc receptor for IgA. J Exp Med 172:1665-1672
21. Marino R, Deibis L, De Sanctis JB, Bianco NE, Toro F (2005) Interaction of immune complexes isolated from hepatitis C virus-infected individuals with human cell lines. Med Microbiol Immunol (Berl) 194:73-80
22. Maruoka T, Nagata T, Kasahara M (2004) Identification of the rat IgA Fc receptor encoded in the leukocyte receptor complex. Immunogenetics 55:712-716
23. Monteiro RC, van de Winkel JG (2003) IgA Fc receptors. Annu Rev Immunol 21:177-204
24. Monteiro RC, Cooper MD, Kubagawa H (1992) Molecular heterogeneity of Fcα receptors detected by receptor-specific monoclonal antibodies. J Immunol 148:1764-1770
25. Monteiro RC, Hostoffer RW, Cooper MD, Bonner JR, Gartland GL, Kubagawa H (1993) Definition of immunoglobulin A receptors on eosinophils and their enhanced expression in allergic individuals. J Clin Invest 92:1681-1685
26. Morton HC, van Egmond M, van de Winkel JG (1996) Structure and function of human IgA Fc receptors (FcαR). Crit Rev Immunol 16:423-440
27. Muller HM, Pfaff E, Goeser T, Kallinowski B, Solbach C, Theilmann L (1993) Peripheral blood leukocytes serve as a possible extrahepatic site for hepatitis C virus replication. J Gen Virol 74(Pt 4):669-676
28. Murawaki Y, Koda M, Okamoto K, Mimura K, Kawasaki H (2001) Diagnostic value of serum type IV collagen test in comparison with platelet count for predicting the fibrotic stage in patients with chronic hepatitis C. J Gastroenterol Hepatol 16:777-781
29. Okamoto H, Sugiyama Y, Okada S, Kurai K, Akahane Y, Sugai Y, Tanaka T, Sato K, Tsuda F, Miyakawa Y, Mayumi M (1992) Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73(Pt 3):673-679
30. Otten MA, van Egmond M (2004) The Fc receptor for IgA (FcαRI, CD89). Immunol Lett 92:23-31
31. Papatheodoridis GV, Delladetsima JK, Katsoulidou A, Sypsa V, Albrecht M, Michel G, Hatzakis A, Tassopoulos NC (1997) Significance of IgM anti-HCV core level in chronic hepatitis C. J Hepatol 27:36-41
32. Pasquier B, Lepelletier Y, Baude C, Hermine O, Monteiro RC (2004) Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells. J Leukoc Biol 76:1134-1141
33. Patry C, Sibille Y, Lehuen A, Monteiro RC (1996) Identification of Fcα receptor (CD89) isoforms generated by alternative splicing that are differentially expressed between blood monocytes and alveolar macrophages. J Immunol 156:4442-4448
34. Peng XX, Wang SY, Zhang JY, Zhu H (2002) Analysis of HCV-immunoglobulin isotype complexes provide new insights into antibody response to HCV. Scand J Immunol 56:94-100
35. Pohl A, Behling C, Oliver D, Kilani M, Monson P, Hassanein T (2001) Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection. Am J Gastroenterol 96:3142-3146
36. Poynard T, Bedossa P, Opolon P (1997) Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups. Lancet 349:825-832
37. Sato S, Fujiyama S, Tanaka M, Goto M, Taura Y, Kawano S, Sato T, Yasuo H (1994) IgM and IgA antibodies generated against hepatitis C virus core antigen in patients with acute and chronic HCV infection. Dig Dis Sci 39:2022-2031
38. Shen L, van Egmond M, Siemasko K, Gao H, Wade T, Lang ML, Clark M, van De Winkel JG, Wade WF (2001) Presentation of ovalbumin internalized via the immunoglobulin-A Fc receptor isenhanced through Fc receptor γ-chain signaling. Blood 97:205-213
39. Shimokawa T, Ra C (2003) C/EBPα and Ets protein family members regulate the human myeloid IgA Fc receptor (FcαR, CD89) promoter. J Immunol 170:2564-2572
40. Shimokawa T, Ra C (2005) C/EBPα functionally and physically interacts with GABP to activate the human myeloid IgA Fc receptor (FcαR, CD89) gene promoter. Blood 106:2534-2542
41. Shimokawa T, Tsuge T, Okumura K, Ra C (2000) Identification and characterization of the promoter for the gene encoding the human myeloid IgA Fc receptor (FcαR, CD89). Immunogenetics 51:945-954
42. Silvain C, Patry C, Launay P, Lehuen A, Monteiro RC (1995) Altered expression of monocyte IgA Fc receptors is associated with defective endocytosis in patients with alcoholic cirrhosis. Potential role for IFN-g. J Immunol 155:1606-1618
43. Simmonds P, Alberti A, Alter HJ, Bonino F, Bradley DW, Brechot C, Brouwer JT, Chan SW, Chayama K, Chen DS et al (1994) A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324
44. Tanaka M, Sato S, Fujiyama S, Kawano S, Taura Y, Chikazawa H, Honda Y, Shibata J, Sato T (1995) Clinical study of IgA antibody against hepatitis C virus core antigen in patients with type C chronic liver disease. Dig Dis Sci 40:457-464
45. Togo S, Shimokawa T, Fukuchi Y, Ra C (2003) Alternative splicing of myeloid IgA Fc receptor (FcαR, CD89) transcripts in inflammatory responses. FEBS Lett 535:205-209
46. Tsuge T, Shimokawa T, Horikoshi S, Tomino Y, Ra C (2001) Polymorphism in promoter region of Fcα receptor gene in patients with IgA nephropathy. Hum Genet 108:128-133
47. van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, van Hattum J, Kuiper J, van de Winkel JG (2000) FcαRI-positive liver Kupffer cells: reappraisal of the function of immunoglobulin A in immunity. Nat Med 6:680-685
48. Wang JT, Sheu JC, Lin JT, Wang TH, Chen DS (1992) Detection of replicative form of hepatitis C virus RNA in peripheral blood mononuclear cells. J Infect Dis 166:1167-1169
49. Watt K, Uhanova J, Gong Y, Kaita K, Doucette K, Pettigrew N, Minuk GY (2004) Serum immunoglobulins predict the extent of hepatic fibrosis in patients with chronic hepatitis C virus infection. J Viral Hepat 11:251-256
50. Woof JM, van Egmond M, Kerr MA (2005) Fc receptors. In: Mestecky J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer L (eds) Mucosal Immunology, 3rd edn. Academic, New York, pp 251-265
51. Yabu K, Kiyosawa K, Mori H, Matsumoto A, Yoshizawa K, Tanaka E, Furuta S (1994) Serum collagen type IV for the assessment of fibrosis and resistance to interferon therapy in chronic hepatitis C. Scand J Gastroenterol 29:474-479
52. Zein NN (2000) Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13:223-235